I-Leflunomide iyisidakamizwa esilwa nesifo samathambo (DMARD). Lo muthi welapha kokubili rheumatoid arthritis kanye ne-psoriatic arthritis ngokunciphisa umsebenzi wamasosha omzimba. Iziguli kufanele zilindele ukusabela kancane kancane kulo muthi. Izimpawu ngokuvamile ziqala ukuba ngcono emasontweni amane kuya kwayisithupha, kodwa izinzuzo ezigcwele zingathatha izinyanga ezine kuya kweziyisithupha ukuze zibonakale.
Lesi sihloko sichaza konke mayelana nomuthi i-leflunomide, okuhlanganisa nokusetshenziswa kwawo, ukuthi kusho ukuthini ezigulini, indlela yawo yokusebenza njengesidakamizwa esilwa nesifo samathambo esishintsha izifo, kanye nemininingwane yokuphepha ebalulekile.
I-Leflunomide igqama kweminye imithi njengengxenye yeqembu elibizwa nge- disease-modifying anti-rheumatic drugs (DMARDs). Lo muthi we-immunosuppressive usebenza njenge-pyrimidine synthesis inhibitor. Lokhu kuvimbela i-enzyme i-dihydroorotate dehydrogenase futhi kusiza ukulondoloza ukusebenza kwamalunga ngokunciphisa i-articular cartilage kanye nokuwohloka kwamathambo. Ungathola lawa maphilisi omlomo ngamandla amathathu:
Odokotela basebenzisa amaphilisi e-leflunomide ukwelapha isifo samathambo esisebenzayo. Umuthi unciphisa izimpawu nezimpawu futhi wehlise ijubane ukuqhubeka kokulimala kwamalunga. Ukwengeza, kusiza iziguli ezinobuhlungu obuhlangene futhi kuthuthukisa ukusebenza kwazo ngokomzimba. Imithi iphinde isebenze kahle nge-psoriatic arthritis, nakuba lokhu kungavunyelwe yi-FDA.
Imiphumela emibi evamile ihlanganisa:
Ukusebenza kwe-Leflunomide kuvela ohlotsheni lwayo olusebenzayo olubizwa nge-teriflunomide. Umuthi uqondise i-enzyme ethile ebizwa ngokuthi i-dihydroorotate dehydrogenase (DHODH) emzimbeni wakho. Le enzyme idlala indima ebalulekile ekuhlanganiseni i-pyrimidine, esiza amaseli ukuba ande.
Umuthi usebenza ngokuvimbela le enzyme futhi uvimbela amaseli omzimba asebenza ngokweqile ukuba aphindaphindeke ngokushesha. Lesi senzo sithinta ngokuyinhloko ama-lymphocyte ayinkinga abangela ukuvuvukala okuhlangene ngaphandle kokuyekethisa amasosha akho omzimba.
Eminye imithi ingaba yingozi uma ihlanganiswa ne-leflunomide:
Ukwelashwa okujwayelekile kulandela le phethini:
Udokotela wakho angase ehlise umthamo ube ngu-10 mg nsuku zonke uma imiphumela emibi ivela. Iziguli eziningi zibona ngcono ngemva kwamaviki angu-4-8, nakuba izinzuzo eziphelele zingathatha izinyanga ezi-4-6.
I-Leflunomide inikeza ikhambi elisebenzayo kubantu abalwa ne-rheumatoid noma i-psoriatic arthritis. Ngokungafani nemithi yezinhlungu evamile, lokhu kwelashwa kuqondise amangqamuzana omzimba angasebenzi ngokweqile ngokuqondile futhi kubambezele ukuqhubeka kwesifo. Ukwelashwa kudinga isineke. Iziguli ngokuvamile zibona imiphumela phakathi kwamaviki angu-4-8, kodwa kuthatha izinyanga ezimbalwa ukubona imiphumela egcwele.
Ukuqonda kahle okuhle nokubi kusiza iziguli zinqume ukuthi yini elungele ukunakekelwa kwazo. Umuthi ungase ungasebenzi kuwo wonke umuntu, kodwa usiza abantu abaningi ukuba balondoloze ukusebenza kwabo okuhlangene futhi baphile izimpilo ezingcono ngaphansi kokunakekelwa okufanele kwezokwelapha.
I-Leflunomide iza nezingozi eziphawulekayo. I-FDA yengeze isexwayiso esinebhokisi mayelana nokulimala okukhulu kwesibindi okungenzeka. Noma kunjalo, umuthi uyasebenza ezigulini eziningi.
Iziguli ngokuvamile zibona ukuthuthuka emavikini angu-4-8 ngemva kokuqala ukwelashwa. Izinzuzo ezigcwele zingase zithathe cishe izinyanga ezingu-6 ukuze zibonakale.
Thatha umthamo ogejiwe uma usukhumbula. Yeqa umthamo ogejiwe uma sekusondele isikhathi sakho esilandelayo futhi unamathele esimisweni sakho esijwayelekile. Akufanele neze uthathe imithamo emibili ngesikhathi esisodwa ukuze ubambe.
Izimpawu ezijwayelekile ze-overdose zihlanganisa:
Thola usizo lwezempilo oluphuthumayo.
I-Leflunomide ayifanele:
Thatha i-leflunomide ngesikhathi esifanayo nsuku zonke. Lokhu kusiza ukugcina amazinga emithi engashintshi egazini lakho. Ungaphuza amaphilisi ngokudla noma ngaphandle kokudla—vele uwagwinye wonke ngamanzi.
Ukwelashwa kweLeflunomide kuvame ukuqhubeka iminyaka eminingi. Kungenzeka ukuyithatha iminyaka engaphezu kwengu-10 uma iqhubeka nokusebenza futhi kungekho miphumela emibi kakhulu eba khona. Ukuhlolwa kwegazi kuyingxenye ebalulekile yokuqapha kukho konke ukwelashwa kwakho.
Udokotela wakho angase akutshele ukuthi uyeke i-leflunomide uma ama-enzyme esibindi sakho ekhuphuka kakhulu, uba nezifo ezimbi kakhulu, noma uba nemiphumela emibi kakhulu. Abesifazane abahlela ukukhulelwa kumele bayeke imithi futhi badlule ohlelweni olukhethekile lokususa umuthi emzimbeni wabo.
Iziguli eziningi zingakwazi ukuthatha i-leflunomide ngokuphepha nsuku zonke. Imiphumela engemihle ivamise ukuvela ekuqaleni kokwelashwa futhi ivama ukushabalala ngokuhamba kwesikhathi. Iphrofayili yemiphumela emibi yomuthi iqhathaniswa kahle namanye ama-DMARD.
Ekuseni kusebenza kangcono njengesikhathi esifanele, ikakhulukazi uma unokudla ukuze unciphise ukucasuka kwesisu. Isikhathi ngokwaso sibalulekile kunokungaguquguquki—sithathe ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga emithi eqinile.
Ucwaningo lubonisa ukuthi i-leflunomide empeleni iholela ekubeni nesizotha kwesisindo.
Ukudla okuluhlaza noma okungaphekiwe kahle kwandisa izingozi zokutheleleka futhi kufanele kugwenywe. Ayikho eminye imikhawulo ethile yokudla esebenza kubasebenzisi be-leflunomide.
Izithasiselo ze-folic acid zinganciphisa imiphumela engemihle njengokukhathala nekhanda ngenkathi zinikeza isivikelo kumaseli esibindi.